USC Schaeffer Center for Health Policy: Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
November 07, 2026
November 07, 2026
LOS ANGELES, California, Nov. 7 -- The University of Southern California Schaeffer Center for Health Policy and Economics issued the following news:
* * *
Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
November 6, 2026
Expanding uses for GLP-1s have not translated into broader coverage
-
Just a fraction of Medicare prescription drug plans cover anti-obesity medications for other purposes . . .
* * *
Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
November 6, 2026
Expanding uses for GLP-1s have not translated into broader coverage
-
Just a fraction of Medicare prescription drug plans cover anti-obesity medications for other purposes . . .
